← Leaderboards
Graham F Carpenter
Vanderbilt University
$8,971,009
Attributed
$8,971,009
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $795.3K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$8,971,009 · 6
By mechanism
R01$6,509,054 · 5
T32$2,461,955 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Neil Osheroff$12,336,075
- Albert B Reynolds$9,738,423
- Dennis E Hallahan$13,109,924
- Robert J Coffey$53,530,293
- Jens Marc Titze$3,594,480
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantLaboratory MouseEnzyme ActivityEpidermal Growth Factor ReceptorSignal TransductionGrantResearch StudyGenetically Modified AnimalsAntibodiesMalignant NeoplasmsGrowth FactorReceptorClinically RelevantBiological Signal TransductionCellsProtein Structure FunctionReceptor ActivationLigandsPhospholipase CEgf GeneCellular BiologyBiochemistryErbituxGrowth
Grant awards (29)
Role of the Sec61 Translocon in EGF Receptor Trafficking and Signaling$308,958
R01 · FY2012 · CA · contact PI
Role of the Sec61 Translocon in EGF Receptor Trafficking and Signaling$308,958
R01 · FY2011 · CA · contact PI
Intracellular Domain Elements in the Regulation of EGF Receptor Kinase Activity$384,958
R01 · FY2010 · GM · contact PI
Role of the Sec61 Translocon in EGF Receptor Trafficking and Signaling$318,513
R01 · FY2010 · CA · contact PI
Intracellular Domain Elements in the Regulation of EGF Receptor Kinase Activity$400,094
R01 · FY2009 · GM · contact PI
Role of the Sec61 Translocon in EGF Receptor Trafficking and Signaling$318,513
R01 · FY2009 · CA · contact PI
Role of the Sec61 Translocon in EGF Receptor Trafficking and Signaling$19,729
R01 · FY2009 · CA · contact PI
Role of the Sec61 Translocon in EGF Receptor Trafficking and Signaling$286,661
R01 · FY2008 · CA · contact PI
Biochemical and Chemical Training for Cancer Research$309,094
T32 · FY2007 · CA · contact PI
Phospholipase C gamma 1--Biochemistry and Biology$368,629
R01 · FY2006 · CA · contact PI
Biochemical and Chemical Training for Cancer Research$334,875
T32 · FY2006 · CA · contact PI
Phospholipase C gamma 1--Biochemistry and Biology$377,500
R01 · FY2005 · CA
Biochemical and Chemical Training for Cancer Research$360,121
T32 · FY2005 · CA
Secretase Processing of ErbB-4 Receptor Tyrosine Kinase$57,649
R01 · FY2005 · CA
Phospholipase C gamma 1--Biochemistry and Biology$377,500
R01 · FY2004 · CA
Biochemical and Chemical Training for Cancer Research$350,346
T32 · FY2004 · CA
Secretase Processing of ErbB-4 Receptor Tyrosine Kinase$319,788
R01 · FY2004 · CA
Phospholipase C gamma 1--Biochemistry and Biology$377,500
R01 · FY2003 · CA
Secretase Processing of ErbB-4 Receptor Tyrosine Kinase$370,854
R01 · FY2003 · CA
Biochemical and Chemical Training for Cancer Research$333,741
T32 · FY2003 · CA
Phospholipase C gamma 1--Biochemistry and Biology$377,813
R01 · FY2002 · CA
Secretase Processing of ErbB-4 Receptor Tyrosine Kinase$301,392
R01 · FY2002 · CA
BIOCHEMICAL AND CHEMICAL TRAINING FOR CANCER RESEARCH$262,136
T32 · FY2002 · CA
PHOSPHOLIPASE C GAMMA 1--BIOCHEMISTRY AND BIOLOGY$418,295
R01 · FY2001 · CA
BIOCHEMICAL AND CHEMICAL TRAINING FOR CANCER RESEARCH$296,667
T32 · FY2001 · CA
RECEPTOR FOR EPIDERMAL GROWTH FACTOR$57,626
R01 · FY2001 · CA
PHOSPHOLIPASE C GAMMA 1--BIOCHEMISTRY AND BIOLOGY$408,550
R01 · FY2000 · CA
RECEPTOR FOR EPIDERMAL GROWTH FACTOR$349,574
R01 · FY2000 · CA
BIOCHEMICAL AND CHEMICAL TRAINING FOR CANCER RESEARCH$214,975
T32 · FY2000 · CA